Beam Therapeutics Inc. (BMV:BEAM)
494.00
+14.00 (2.92%)
At close: Oct 9, 2025
Beam Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Cash & Equivalents | 282.13 | 281.97 | 435.9 | 232.77 | 559.99 | 162.17 | Upgrade |
Short-Term Investments | 868.21 | 568.77 | 753.98 | 845.37 | 405.65 | 137.5 | Upgrade |
Cash & Short-Term Investments | 1,150 | 850.74 | 1,190 | 1,078 | 965.65 | 299.67 | Upgrade |
Cash Growth | 14.10% | -28.50% | 10.36% | 11.65% | 222.24% | 226.27% | Upgrade |
Other Receivables | - | - | - | - | 300 | - | Upgrade |
Total Trade Receivables | - | - | - | - | 300 | - | Upgrade |
Other Current Assets | 31.76 | 35.55 | 29.89 | 27.52 | 20.11 | 23.49 | Upgrade |
Total Current Assets | 1,175 | 878.15 | 1,211 | 1,093 | 1,273 | 308.32 | Upgrade |
Net Property, Plant & Equipment | 208.39 | 216.28 | 237.81 | 234.13 | 186.98 | 125.37 | Upgrade |
Other Long-Term Assets | 0.67 | 1.25 | 2.15 | 1.93 | 1.72 | 3.14 | Upgrade |
Total Assets | 1,391 | 1,104 | 1,460 | 1,342 | 1,474 | 451.68 | Upgrade |
Accounts Payable | 10.56 | 3.87 | 1.62 | 9.03 | 7.47 | 6.31 | Upgrade |
Accrued Expenses | 40.9 | 47.47 | 111.66 | 49.91 | 67.66 | 18.46 | Upgrade |
Short-Term Debt | - | - | - | - | 2.29 | 2.12 | Upgrade |
Current Portion of Leases | 12.95 | 13.47 | 12.78 | 10.38 | 7.54 | 4.22 | Upgrade |
Unearned Revenue | 105.82 | 108.86 | 68.71 | 135.97 | 86.27 | 0.02 | Upgrade |
Other Current Liabilities | 3.9 | 8.4 | 10.8 | 18.3 | 42.2 | 71.2 | Upgrade |
Total Current Liabilities | 174.13 | 182.07 | 205.57 | 223.6 | 213.44 | 102.34 | Upgrade |
Long-Term Debt | - | - | - | - | 3.01 | 5.29 | Upgrade |
Long-Term Leases | 141.85 | 147.96 | 159.91 | 168.63 | 134.81 | 96.01 | Upgrade |
Other Long-Term Liabilities | 28.36 | 40.26 | 112.91 | 216.02 | 296.46 | 2.47 | Upgrade |
Total Long-Term Liabilities | 170.21 | 188.21 | 272.82 | 384.65 | 434.28 | 103.78 | Upgrade |
Total Liabilities | 344.34 | 370.28 | 478.39 | 608.24 | 647.72 | 206.12 | Upgrade |
Common Stock | 1.01 | 0.84 | 0.82 | 0.71 | 0.68 | 0.57 | Upgrade |
Additional Paid-in Capital | 2,824 | 2,299 | 2,170 | 1,793 | 1,594 | 642.63 | Upgrade |
Accumulated Other Comprehensive Income | 0.01 | 0.68 | 0.6 | -2.43 | -0.05 | -0.01 | Upgrade |
Retained Earnings | -1,778 | -1,567 | -1,190 | -1,057 | -768.27 | -397.64 | Upgrade |
Shareholders' Equity | 1,047 | 733.55 | 981.33 | 733.47 | 826.74 | 245.56 | Upgrade |
Total Liabilities & Equity | 1,391 | 1,104 | 1,460 | 1,342 | 1,474 | 451.68 | Upgrade |
Total Debt | 154.8 | 161.43 | 172.69 | 179.01 | 147.64 | 107.64 | Upgrade |
Net Cash (Debt) | 995.53 | 689.32 | 1,017 | 899.13 | 818 | 192.03 | Upgrade |
Net Cash Growth | 44.42% | -32.23% | 13.13% | 9.92% | 325.98% | 216.82% | Upgrade |
Net Cash Per Share | 11.21 | 8.37 | 13.18 | 12.84 | 12.74 | 4.11 | Upgrade |
Book Value | 1,047 | 733.55 | 981.33 | 733.47 | 826.74 | 245.56 | Upgrade |
Book Value Per Share | 11.79 | 8.91 | 12.72 | 10.48 | 12.87 | 5.25 | Upgrade |
Tangible Book Value | 1,047 | 733.55 | 981.33 | 733.47 | 826.74 | 245.56 | Upgrade |
Tangible Book Value Per Share | 11.79 | 8.91 | 12.72 | 10.48 | 12.87 | 5.25 | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.